Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Ixekizumab has known and some unexpected side effects.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Certain drugs may cause vitiligo, so patients should be monitored.

No conclusions about the effectiveness of Compound Jinqiancao Granules for prostatitis can be made.

Ritlecitinib improves hair growth and quality of life in severe alopecia areata with longer use.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

More effective treatments are needed for severe alopecia areata.

Montelukast is linked to increased risks of suicidal thoughts and depression.

Google Search ads effectively gathered a diverse dermatology image dataset for research and AI development.

Finasteride is most linked to drug-induced erectile dysfunction.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Topical finasteride effectively and safely improves hair growth in men with androgenetic alopecia.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Most patients were satisfied with topical finasteride, and few experienced side effects.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Finasteride use may increase suicidality risk, especially in young men.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Topical finasteride is well-tolerated and satisfies most users with minimal side effects.

JAK inhibitors show promise for treating alopecia areata, but long-term safety and emotional support are important.

New treatments are improving alopecia areata care, but long-term safety needs more study.

New therapies for alopecia areata show promise but need more research and collaboration.

Semaglutide does not significantly increase the risk of hair loss.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.